JUVÉDERM® VOLLURE® XC is a hyaluronic acid (HA) dermal filler designed to address moderate to severe facial wrinkles and folds, particularly the nasolabial folds. It is formulated with VYCROSS® technology, which provides a unique balance of gel properties.
This balance allows it to offer subtle, softer volume, resulting in a natural look with minimal swelling and long-lasting results. JUVÉDERM® VOLLURE® XC is the first and only HA dermal filler FDA-approved to correct moderate to severe facial wrinkles and folds for up to 18 months. It is often used in the lower face to restore natural-looking contours and smooth deep wrinkles, such as the nasolabial folds.
The JUVÉDERM® Collection of Fillers includes various products tailored for different treatment areas and patient needs. JUVÉDERM® VOLLURE® XC is uniquely formulated to provide a discreet, natural look with long-lasting results, making it a popular choice for patients seeking to address facial wrinkles and folds, particularly in the lower face.
If you are looking to stock up on JUVEDERM® VOLLURE XC, we offer easy access and competitive pricing to meet all your practice's needs. Elevate your service offerings and patient satisfaction now by placing your order today.
JUVÉDERM® VOLLURE® XC and JUVÉDERM® VOLUMA® XC are both part of the JUVÉDERM® Collection of Fillers, but they are designed for different treatment areas and patient needs. JUVÉDERM® VOLLURE® XC is specifically tailored for smoothing moderate to severe facial wrinkles and folds, such as nasolabial folds, and for adding subtle, softer volume. It is formulated with VYCROSS® technology, which provides a unique balance of gel properties, making it firmer and more cohesive than JUVÉDERM® VOLBELLA® XC, but less firm than JUVÉDERM® VOLUMA® XC.
JUVÉDERM® VOLUMA® XC, on the other hand, is designed for deep injection in the cheek area to correct age-related volume loss and for augmentation of the chin region. It provides a more dramatic change and is stronger and denser than JUVÉDERM® VOLLURE® XC.
The potential side effects of JUVÉDERM® VOLLURE® XC, as reported in the clinical study, include temporary reactions at the treatment site such as tenderness, swelling, firmness, lumps/bumps, bruising, pain, redness, and discoloration. These side effects are usually mild or moderate and typically last 2 to 4 weeks. Less common side effects may include itching and adverse events such as lumps/bumps, firmness, swelling, and pain, which were seen more frequently in subjects who received a large volume of the product and in older subjects. It is important to contact your doctor if you experience significant pain away from the injection site, prolonged redness and/or swelling, or any other unexpected side effects. Overall, the most common side effects are consistent with those of other facial-injection procedures and are generally mild to moderate.
JUVÉDERM® VOLLURE® XC is designed to temporarily correct moderate to severe facial wrinkles and folds, such as nasolabial folds, and can last up to 18 months with optimal treatment
We pride ourselves on fast, efficient delivery, ensuring your products arrive when you need them, so you can continue providing uninterrupted care.
Medical aesthetic treatments continue to advance, offering patients more options than ever before. For medical professionals seeking the most effective solutions for their patients, the challenge lies in selecting products that deliver consistent, natural-looking results with minimal downtime. The nasolabial folds and facial wrinkles that patients frequently seek to address require specialized treatments that balance immediate improvement with lasting outcomes.
Every medical practice understands the importance of patient satisfaction in building a thriving aesthetic business. When patients see visible, natural-looking results that last, they become loyal clients and referral sources. The challenge many medical professionals face is finding a dermal filler that effectively addresses moderate to severe facial wrinkles and folds while providing the longevity patients desire.
The impact of choosing the right dermal filler extends beyond patient satisfaction to your practice’s bottom line. Treatments that require less frequent maintenance visits while delivering superior results enhance your reputation as a provider of quality aesthetic care. This directly affects patient retention rates and practice growth.
JUVÉDERM® VOLLURE® XC stands apart in the marketplace of hyaluronic acid dermal fillers through its innovative formulation and application techniques. This advanced injectable gel utilizes VYCROSS® technology, a proprietary manufacturing process that creates a more connected gel, resulting in a balance of lift capacity and flexibility that moves naturally with facial expressions.
When comparing JUVÉDERM® VOLLURE® XC to other fillers in the JUVÉDERM® Collection, its unique position becomes clear. While JUVÉDERM® VOLUMA® XC addresses volume loss in the cheeks and JUVÉDERM® VOLBELLA® XC targets the lips, JUVÉDERM® VOLLURE® XC specifically excels at treating moderate to severe facial wrinkles and folds, particularly the nasolabial area.
The development of JUVÉDERM® VOLLURE® XC represents a significant advancement in dermal filler technology. Its formulation allows for more efficient cross-linking of hyaluronic acid molecules, creating a gel that maintains its shape while adapting to facial movements. This provides a natural look and feel that patients increasingly demand.
The VYCROSS® technology in JUVÉDERM® VOLLURE® XC combines low and high molecular weight hyaluronic acid. This innovative approach creates a tightly cross-linked gel that resists degradation in the body, contributing to its impressive duration of up to 18 months in many patients.
When JUVÉDERM® VOLLURE® XC is injected into the facial tissues, it integrates smoothly with the skin’s structure. The gel’s cohesivity ensures it stays where placed without migrating, while its elasticity allows it to move naturally with facial expressions. This balance is crucial for achieving results that look and feel authentic.
The hyaluronic acid in JUVÉDERM® VOLLURE® XC works by attracting and holding water molecules, adding volume beneath the skin’s surface. This action effectively lifts and smooths moderate to severe facial wrinkles and folds. As a naturally occurring substance in the body, hyaluronic acid provides biocompatibility that reduces the risk of adverse reactions.
JUVÉDERM® VOLLURE® XC delivers exceptional results for patients seeking treatment for moderate to severe facial wrinkles and folds. Clinical studies have demonstrated its effectiveness in reducing the appearance of nasolabial folds with results lasting up to 18 months in a significant percentage of patients, making it one of the longest-lasting treatments for this concern.
The versatility of JUVÉDERM® VOLLURE® XC allows medical professionals to address various depth wrinkles with a single product. Its malleable consistency works effectively for smoothing deeper nasolabial folds while also treating finer lines around the mouth. This versatility simplifies inventory management while expanding treatment capabilities.
Patients consistently report high satisfaction with JUVÉDERM® VOLLURE® XC treatments. The natural-looking results, combined with the extended duration of effect, contribute to positive experiences and strong word-of-mouth referrals. This patient satisfaction directly benefits practice growth and reputation.
Successful JUVÉDERM® VOLLURE® XC treatment begins with proper patient assessment. Medical professionals should evaluate skin quality, wrinkle depth, and facial dynamics to determine optimal injection points and volumes. This personalized approach ensures the most natural-looking results.
The injection technique significantly impacts outcomes with JUVÉDERM® VOLLURE® XC. Most practitioners find that a combination of linear threading and small bolus injections provides optimal correction of nasolabial folds. The product should be placed in the mid to deep dermis for best results.
Post-treatment protocols enhance patient comfort and results. Gentle massage of the treated area helps distribute the product evenly. Patients should be advised to avoid strenuous exercise, excessive sun exposure, and alcohol consumption for 24 hours following treatment to minimize the risk of inflammation at the treatment site.
Identifying ideal candidates for JUVÉDERM® VOLLURE® XC involves assessing both physical characteristics and expectations. The best candidates typically present with moderate to severe nasolabial folds, good skin quality, and realistic outcome expectations. Proper candidate selection significantly improves satisfaction rates.
Pre-treatment consultations should include a thorough discussion of potential side effects. While JUVÉDERM® VOLLURE® XC has an excellent safety profile, patients should be informed about common side effects such as injection-site redness, tenderness, bruising, itching, and discoloration. These effects are typically mild to moderate and resolve within a week.
The safety of JUVÉDERM® VOLLURE® XC requires careful attention to contraindications. The product should not be used in patients with severe allergies manifested by a history of anaphylaxis, in patients with allergies to gram-positive bacterial proteins used in the manufacturing process, or in areas with active inflammation or infection.
Most patients experience mild to moderate side effects after JUVÉDERM® VOLLURE® XC treatment. The most common include injection site reactions such as redness, pain, tenderness, swelling, bruising, and itching. These typically resolve within 2-7 days without intervention.
To minimize bruising and discoloration, medical professionals can implement several strategies. These include avoiding JUVÉDERM® VOLLURE® XC treatment in patients taking blood thinners when possible, using small-gauge needles, applying cold compresses before and after treatment, and employing gentle injection techniques.
Patient education about post-treatment care significantly reduces complication risks. Instructions should include avoiding makeup for 12 hours post-treatment, minimizing sun exposure, avoiding excessive heat (including saunas and hot yoga), and refraining from alcohol consumption for 24 hours following treatment.
The long-term safety profile of JUVÉDERM® VOLLURE® XC is well-established through clinical studies and post-market surveillance. The biocompatible nature of hyaluronic acid contributes to its favorable safety record, with serious adverse events being exceedingly rare when administered by qualified medical professionals.
Medical practices should maintain detailed records of all JUVÉDERM® VOLLURE® XC treatments, including lot numbers, injection sites, techniques used, and patient responses. This documentation supports patient safety and helps identify any patterns in the rare event of adverse reactions.
In the extremely rare case of serious complications such as vascular occlusion, medical professionals should have established emergency protocols. Having hyaluronidase available and training staff on recognition and management of serious adverse events demonstrates a commitment to patient safety.
Within the JUVÉDERM® Collection, each product serves a specific purpose in facial rejuvenation. JUVÉDERM® VOLUMA® XC specializes in adding volume to the cheek area, while JUVÉDERM® VOLBELLA® XC targets lips and perioral lines. JUVÉDERM® VOLLURE® XC fills the critical niche of treating nasolabial folds and other moderate to severe facial wrinkles.
The duration of effect varies among JUVÉDERM® products. JUVÉDERM® VOLUMA® XC can last up to 24 months in the cheeks, while JUVÉDERM® Ultra XC typically lasts 12 months in the lips. JUVÉDERM® VOLLURE® XC’s duration of up to 18 months for nasolabial folds positions it as a long-lasting option that requires less frequent maintenance.
Medical practices often benefit from offering multiple JUVÉDERM® Collection products to address various patient needs comprehensively. This approach allows for customized treatment plans that may combine JUVÉDERM® VOLUMA® XC in the cheeks, JUVÉDERM® VOLLURE® XC for nasolabial folds, and JUVÉDERM® VOLBELLA® XC for lip enhancement and perioral lines.
When comparing JUVÉDERM® VOLLURE® XC to similar products from different manufacturers, several distinguishing factors emerge. The VYCROSS® technology provides a balance of durability and flexibility that many practitioners find superior for treating dynamic areas like nasolabial folds.
The longevity of JUVÉDERM® VOLLURE® XC presents a significant advantage for both patients and practices. With results lasting up to 18 months, patients require fewer treatment sessions compared to products that typically last 6-12 months. This extended duration improves the treatment’s value proposition.
The natural feel of JUVÉDERM® VOLLURE® XC sets it apart from some competitor products that may feel firmer or more palpable under the skin. Patients frequently report satisfaction with the natural integration of JUVÉDERM® VOLLURE® XC into facial tissues, which maintains natural facial movements and expressions.
Streamlining the procurement process for JUVÉDERM® VOLLURE® XC ensures product availability when needed. Establishing a relationship with a reliable marketplace like Pipeline Medical provides access to authentic products with efficient supply chain procurement that minimizes administrative burden.
Inventory management requires balancing sufficient stock with expiration date monitoring. Most medical practices find that maintaining a 4-6 week supply of JUVÉDERM® VOLLURE® XC optimizes cash flow while ensuring product availability. Regular inventory audits prevent shortages that could disrupt scheduled treatments.
Storage and handling protocols for JUVÉDERM® VOLLURE® XC must be strictly followed. The product should be stored at room temperature (up to 25°C/77°F) and protected from direct sunlight. Proper handling preserves product integrity and ensures optimal patient outcomes.
Educating existing patients about JUVÉDERM® VOLLURE® XC creates awareness and generates interest. Effective approaches include in-office displays, patient newsletters highlighting the benefits of long-lasting results, and before-and-after photos that demonstrate natural-looking outcomes.
Digital marketing strategies should emphasize the unique benefits of JUVÉDERM® VOLLURE® XC, particularly its duration and natural results. Content marketing that addresses common questions about facial aging and treatment options positions your practice as an educational resource while introducing JUVÉDERM® VOLLURE® XC as a solution.
Internal staff training ensures consistent messaging about JUVÉDERM® VOLLURE® XC. Front desk staff, medical assistants, and practitioners should understand the product’s key benefits, ideal candidates, and how it compares to alternatives. This knowledge builds confidence in recommending the treatment to appropriate patients.
JUVÉDERM® VOLLURE® XC often produces optimal results when integrated into a holistic facial rejuvenation approach. Combining JUVÉDERM® VOLLURE® XC for nasolabial folds with complementary treatments like JUVÉDERM® VOLUMA® XC for cheek volume and neurotoxins for dynamic wrinkles delivers comprehensive improvement.
Treatment sequencing affects outcomes when using multiple modalities. Many practitioners prefer addressing volume loss with JUVÉDERM® VOLUMA® XC before treating nasolabial folds with JUVÉDERM® VOLLURE® XC. This approach often reduces the amount of JUVÉDERM® VOLLURE® XC needed and produces more natural-looking results.
Follow-up protocols ensure patient satisfaction and optimal outcomes. Scheduling a review appointment 2-4 weeks after JUVÉDERM® VOLLURE® XC treatment allows for assessment and any necessary touch-ups. This proactive approach demonstrates commitment to results and builds patient trust.
Clear communication about expected outcomes prevents disappointment. Patients should understand that while JUVÉDERM® VOLLURE® XC provides significant improvement in moderate to severe facial wrinkles and folds, results vary based on individual factors such as age, skin condition, and wrinkle severity.
Visual aids enhance patient understanding of potential JUVÉDERM® VOLLURE® XC results. Before-and-after photos of patients with similar concerns help set appropriate expectations. Digital imaging can also illustrate potential outcomes, though it should be presented as an approximation rather than a guarantee.
Discussing the gradual nature of facial aging helps patients understand the need for ongoing maintenance. Even with JUVÉDERM® VOLLURE® XC’s impressive duration of up to 18 months, the aging process continues. Patients appreciate honest discussions about the need for periodic treatments to maintain results long-term.
Comfort measures significantly improve the JUVÉDERM® VOLLURE® XC treatment experience. While the product contains lidocaine to reduce discomfort, additional techniques such as topical anesthetics, ice application, and vibration devices can further enhance comfort during injection.
Creating a relaxing environment contributes to a positive experience. Attention to details such as comfortable treatment chairs, soothing music, and a calm atmosphere helps reduce anxiety. Some practices offer stress-reducing amenities like aromatherapy or warm blankets.
Post-treatment care instructions should be provided both verbally and in writing. Clear guidance on managing common side effects, activities to avoid, and when to contact the practice ensures patients feel supported throughout their recovery. This comprehensive care enhances satisfaction with both the treatment and the practice.
Developing a personalized maintenance schedule for each JUVÉDERM® VOLLURE® XC patient optimizes long-term results. While the product lasts up to 18 months in many patients, individual factors affect longevity. A customized plan might recommend reassessment at 12 months with touch-ups as needed.
Combination therapy approaches often enhance and extend JUVÉDERM® VOLLURE® XC results. Complementary treatments such as medical-grade skincare, laser therapy, or microneedling address skin quality while JUVÉDERM® VOLLURE® XC corrects volume loss and wrinkles. This comprehensive approach maximizes patient satisfaction.
Patient loyalty increases with consistent follow-up. A structured program of periodic assessments demonstrates commitment to long-term results and provides opportunities to address emerging concerns. This proactive approach strengthens the patient-practice relationship and encourages treatment adherence.
JUVÉDERM® VOLLURE® XC utilizes proprietary VYCROSS® technology that creates a more connected hyaluronic acid gel. This unique formulation provides the ideal balance of structure and flexibility, allowing for natural movement while maintaining correction. The technology also contributes to its longevity of up to 18 months.
The versatility of JUVÉDERM® VOLLURE® XC sets it apart from many alternatives. Its formulation makes it effective for treating various facial areas, particularly moderate to severe wrinkles and folds like nasolabial folds. The product flows smoothly during injection while maintaining its shape after placement.
JUVÉDERM® VOLLURE® XC contains lidocaine for enhanced patient comfort during treatment. This integrated anesthetic reduces discomfort during the injection process, improving the overall treatment experience compared to products without lidocaine.
Clinical studies demonstrate that JUVÉDERM® VOLLURE® XC can last up to 18 months in a majority of patients. This duration represents a significant advantage over many comparable products that typically require maintenance every 6-12 months.
Individual factors affect how long JUVÉDERM® VOLLURE® XC results last. These include the patient’s age, metabolism, facial movement patterns, and the area treated. Patients with very active facial movements may experience slightly shorter durations than the clinical average.
Maintenance treatments can extend the benefits of JUVÉDERM® VOLLURE® XC. Many practitioners recommend a touch-up approach, where smaller amounts are added before complete product metabolism. This strategy often maintains consistent results with less product over time.
The JUVÉDERM® VOLLURE® XC treatment process typically takes 15-30 minutes, depending on the areas treated. After cleansing the skin, the medical professional will inject the product using techniques appropriate for the specific treatment areas and desired outcomes.
During the injection, patients may feel mild pressure or a pinching sensation. The integrated lidocaine in JUVÉDERM® VOLLURE® XC helps minimize discomfort, and most patients report only minimal pain during the procedure. Results are visible immediately, though optimal results emerge after any initial swelling subsides.
Post-treatment recovery involves managing common side effects such as temporary redness, swelling, tenderness, bruising, itching, and discoloration at the injection site. These typically resolve within 2-7 days. Most patients can return to normal activities immediately, though strenuous exercise should be avoided for 24 hours following treatment.
JUVÉDERM® VOLLURE® XC represents a significant advancement in dermal filler technology, offering medical practices an effective solution for patients seeking long-lasting correction of moderate to severe facial wrinkles and folds. Its unique formulation delivers natural-looking results that maintain facial expressiveness while providing correction that lasts up to 18 months.
The integration of JUVÉDERM® VOLLURE® XC into your practice extends beyond adding a new treatment option. It enhances your ability to provide comprehensive facial rejuvenation, improves patient satisfaction through longer-lasting results, and demonstrates your commitment to offering advanced aesthetic solutions.
Partner with Pipeline Medical to streamline your JUVÉDERM® VOLLURE® XC procurement process. Our marketplace simplifies supply chain procurement, ensuring reliable access to authentic products while reducing administrative burden. This efficiency allows your practice to focus on what matters most—delivering exceptional patient care and outcomes.
The information provided on this site is for informational purposes only and is not intended to substitute for professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider or medical professional for guidance on any medical concerns, product use, or treatment decisions.
If you have more questions, our sales team is ready to assist you. Reach out to our customer service team for personalized support and answers to all your inquiries.